Healthcare Value Capital’s Assertio ASRT Stock Holding History

Healthcare Value Capital’s Portfolio ASRT Stock Details ASRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,000	Closed	-$2.43M	–	13
2017 Q3	$2.43M	Buy	+7,000	New	+$3.3M	4.87%	7

Other funds holding ASRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Healthcare Value Capital's ASRT Position: Q4 2017 in Review

Healthcare Value Capital sold out of Assertio (ASRT) in Q4 2017, closing a stake of 11,667 shares — an estimated $4.05M sold.

Healthcare Value Capital first reported a position in ASRT in Q4 2015 and held it in 8 quarters. The position peaked at $8.74M in Q3 2016. 160 funds tracked by Wall St. Rank hold ASRT as of Q4 2017.

Healthcare Value Capital reported no remaining Assertio position as of Q4 2017 after selling out during the quarter.
Healthcare Value Capital sold 11,667 Assertio shares in Q4 2017, an estimated $4.05M.
Healthcare Value Capital first reported a position in Assertio in Q4 2015 and held it in 8 quarters.
Healthcare Value Capital's Assertio position peaked at $8.74M in Q3 2016.
160 funds tracked by Wall St. Rank held Assertio as of Q4 2017.

Based on Healthcare Value Capital's 13F filing for Q4 2017, filed 23 Jan 2018.